Europe Knee Cartilage Repair Market, By Treatment (Cell Based & Non-Cell Based), Surgery (Autologous Chondrocyte Implantation, Microfracture, Abrasion Arthroplasty, Drilling, Osteochondral Autograft Transplantation, Osteochondral Allograft Transplantation & Other), Devices (Implants, Arthroscopy, Resurfacing, Osteotomy, Bone Graft, Arthrodesis & Others), Application (Osteoarthritis, Rheumatoid Arthritis, Osteonecrosis, Fracture, & Bone Tumor), End User (Hospitals, Ambulatory Surgical Centers & Independent Centers), Distribution Channel (Direct Sales, Third Party Distributors, Online Sales & Others) – Industry Trends and Forecasts to 2029.
Europe Knee Cartilage Repair Market Analysis and Insights
The knee is the largest joint in the body. The upper and lower bones of the knee are separated by two discs (menisci). The upper leg bone (femur) and the lower leg bones (tibia and fibula) are connected by ligaments and tendons. The cartilage is the most common type of connective tissue. It is found in various forms throughout our joints, spine, bones, ears, lungs, and nose. Cartilage is a flexible connective tissue which coats the surfaces of the bones in our joints and protects them against impact to maintain joint mobility fluid.
The knee cartilage repair is a procedure which involves repairing damaged cartilage while also smoothing the tissue’s remaining surface. The cartilage repair surgery, which attempts to restore cartilage tissue and function to avoid long-term osteoarthritis (OA), is an appropriate treatment choice for focal full-thickness cartilage abnormalities in the knee. The osteotomy, knee replacement, microfracture are some of the most common knee cartilage repair techniques. The surgical techniques or less prevalent surgical procedures, such as allograft osteochondral transplantation, autologous chondrocyte implantation and artificial scaffolds, are sometimes utilized to repair cartilage injury.
Data Bridge Market Research analyses that the Europe knee cartilage repair market will grow at a CAGR of 9.7% during the forecast period of 2022 to 2029.
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019-2014)
|
|
Quantitative Units
|
Revenue in USD Million, Pricing in USD
|
|
Segments Covered
|
Treatment (Cell Based & Non-Cell Based), Surgery (Autologous Chondrocyte Implantation, Microfracture, Abrasion Arthroplasty, Drilling, Osteochondral Autograft Transplantation, Osteochondral Allograft Transplantation & Other), Devices (Implants, Arthroscopy, Resurfacing, Osteotomy, Bone Graft, Arthrodesis & Others), Application (Osteoarthritis, Rheumatoid Arthritis, Osteonecrosis, Fracture, & Bone Tumor), End User (Hospitals, Ambulatory Surgical Centers & Independent Centers), Distribution Channel (Direct Sales, Third Party Distributors, Online Sales & Others)
|
|
Countries Covered
|
Germany, Italy, France, Switzerland, U.K., Sweden, Spain, Russia, Belgium, Netherlands, Turkey & Rest of Europe
|
|
Market Players Covered
|
Stryker (U.S.), Zimmer Biomet (U.S.), B. Braun Melsungen AG (Germany), Smith & Nephew (U.K.), BioTissue (U.S.), JRI Orthopedics (U.K.), CONMED (U.S.), Mathys Ltd Bettlach (Switzerland), Johnson & Johnson Services, Inc. (U.S.), Medacta International (Switzerland), Meril Life Sciences Pvt Ltd. (India), Hy2Care (Netherlands), Regentis Biomaterials Ltd. (Israel), and Waldemar Link GmbH & Co. KG (Germany)
|
Osteoporosis Drugs Market Dynamics
Drivers
- High prevalence of knee disorders
The common knee disease which occurs in Europe is knee osteoarthritis. Knee osteoarthritis accounts for almost four fifths of the burden of OA worldwide and increases with obesity and age. Knee diseases, especially the knee osteoarthritis, are common and a major cause of disability among the elderly population.
For instance,
- According to Global Burden of Disease Data, in 2019, over 57 million people in Western Europe have osteoarthritis (OA). The disease caused the loss of over 2 million years of healthy life
The rise in incidence of chronic knee disorders is expected to boost the sales and supply of the implants for treatment of cartilage repair in Europe. It would meet the patient requirements and hence is expected to drive the growth of the market.
- Growing geriatric population
Knee disorders, namely the knee osteoarthritis and ligament tear are the common in the elderly population in Europe. The adults, aged 60 years and above and particularly living in long-term care facilities, are likely to suffer from bone disorders. As ageing increases, the burden of knee disorders in the geriatric population may increase, which paves the way for development of medications and implants in diagnostic and prevention strategies critical for improving the knee disorders of older adults.
For instance,
- According to Eurostat, in 2021, more than one fifth of the EU population (20.8 %), was aged 65 and over
As the geriatric population suffering from chronic knee increases, it would result in increased demand of treatment. Therefore, the rise in geriatric population is expected to boost the growth of the market.
Opportunities
- Rise in awareness about knee treatment in Europe
Awareness about the symptoms and treatment of chronic knee diseases, by public and private institutes would result in timely treatment and also provide the option to access to inexpensive universal health aid along with increased availability of rehabilitative treatment. The European Knee Society (EKS) was created to bring the European key opinion leaders in the field of the degenerative knee and knee arthroplasty.
For instance,
- In November 2020, the European Knee Society (EKS) had collaborated with the Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Italy, for organizing two fellowships and creating awareness about treatment on primary and revision knee replacement
This will result in rise in product and business line expansion. Hence, rise in awareness among people about the timely treatment is expected to act as opportunity for the growth of the market.
- Rise in number of knee surgeries
Hip and knee replacements are some of the most frequently performed and effective surgeries in Europe region.
For instance,
- The data by the National Joint Registery states that approximately, 160,000 total hip and knee replacement procedures performed each year, in England and Wales
Technological development would be of crucial importance in the development of advanced knee implants. Thus the increase in numbers of surgeries performed is expected to act as opportunity for the growth of the market.
Restraints/Challenges
- High cost of orthopaedic knee implants and surgeries
Knee arthroplasty is a popular procedure, but exhibits high cost. The rise in cost of the knee implants are due to technological development and the rising preference for less invasive orthopedic knee implants.
The cost of Autologous Chondrocyte Implantation (ACI) is expensive. According to ProHealth Clinic U.K., it costs around $40,000. The Osteochondral allograft transplantation is a specialized procedure. Its cost is thus high depending upon the cost of the allografts. It ranges around $10,000. Hence, it is expected to hamper the market growth.
This knee cartilage repair market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on lab supplies market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
Orthopedic diseases continue to rise throughout the globe. Osteoarthritis is caused by inflammation, breakdown, and the gradual and eventual loss of cartilage in the joints. Over time, the cartilage wears down and the bones rub together.
According to Arthritis Research UK, approximately 1 in 5 adults (18.2.%), over 45 years of age has knee osteoporosis in England. According to report by the Oxford Academic, the incidence of knee osteoarthritis, were reported to show highest number of cases in the U.K., followed by France, Germany , Spain and Italy, showing the less record cases of knee osteoarthritis
This knee cartilage repair market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohot multivariate statistical model for forecasting the market in growth period.
Post COVID-19 Impact on Lab supplies market
The COVID-19 has negatively affected the market. Lockdowns and isolations during pandemic complicates the disease management and medication adherence. The lack of access to healthcare facilities for routine treatment and medication administration has impacted the market.
Recent Development
- In March 2022, Johnson & Johnson Services, Inc. announced the launch of new products to its knee portfolio, ATTUNE cementless fixed bearing knee with AFFIXIUM 3DP Technology and the ATTUNE Medial Stabilized Knee System. These innovations build on the kinematic features which are designed to revolutionize knee patient care. This has helped the company to increase its knee product portfolio
Europe Knee Cartilage Repair Market Scope
The knee cartilage repair market is categorized into six notable segments based on treatment, surgery, devices, application, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Treatment
- Cell Based
- Non-Cell based
Based on treatment, Europe knee cartilage repair market is segmented into cell based and non-cell based.
Surgery
- Autologous Chondrocyte Implantation
- Microfracture
- Drilling
- Abrasion Arthroplasty
- Osteochondral Allograft Transplantation
- Osteochondral Autograft Transplantation
- Others
Based on surgery, Europe knee cartilage repair market is segmented into autologous chondrocyte implantation, microfracture, drilling, abrasion arthroplasty, osteochondral allograft transplantation, osteochondral autograft transplantation and others
Devices
- Implants
- Arthroscopy
- Bone Graft
- Osteotomy
- Resurfacing
- Arthrodesis
- Others
Based on devices, Europe knee cartilage repair market is segmented into implants, arthroscopy, bone graft, osteotomy, resurfacing, arthrodesis and others.
Application
- Osteoarthritis
- Rheumatoid Arthritis
- Bone Tumor
- Fracture
- Osteonecrosis
Based on application, Europe knee cartilage repair market is segmented into osteoarthritis, rheumatoid arthritis, bone tumor, fracture and osteonecrosis.
End User
- Hospitals
- Ambulatory Surgical Centers
- Independent Centers
Based on end user, Europe knee cartilage repair market is segmented into hospitals, ambulatory surgical centers and independent centers.
Distribution Channel
- Direct Sales
- Third Party Distributors
- Online Sales
- Others
Based on distribution channel, Europe knee cartilage repair market is segmented into direct sales, third party distributors, online sales and others.
Knee Cartilage Repair Regional Analysis/Insights
The knee cartilage repair market is analysed and market size insights and trends are provided by country, treatment, surgery, devices, application, end user, and distribution channel.as referenced above.
The regions covered in the Europe knee cartilage repair market report are Germany, Italy, France, Switzerland, U.K., Sweden, Spain, Russia, Belgium, Netherlands, Turkey & Rest of Europe.
Germany is expected to dominate the Europe knee cartilage repair market due to the presence of advanced technology, high prevalence of knee osteoarthritis and established health care system.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Knee Cartilage Repair Market Share Analysis
The knee cartilage repair market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Saudi Arabia presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to osteoporosis durgs market.
Some of the major players operating in the Europe knee cartilage repair market are Stryker, Zimmer Biomet, B. Braun Melsungen AG, Smith & Nephew, BioTissue, JRI Orthopedics, CONMED, Mathys Ltd Bettlach, Johnson & Johnson Services, Inc., Medacta International, Meril Life Sciences Pvt Ltd., Hy2Care, Regentis Biomaterials Ltd., and Waldemar Link GmbH & Co. KG among others.
SKU-